BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 924012)

  • 21. Further characterization of the second oestrogen-binding species of the rat granulosa cell.
    Kudolo GB; Elder MG; Myatt L
    J Endocrinol; 1984 Jul; 102(1):93-102. PubMed ID: 6736855
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A monohydroxylated metabolite of tamoxifen with potent antioestrogenic activity.
    Jordan VC; Collins MM; Rowsby L; Prestwich G
    J Endocrinol; 1977 Nov; 75(2):305-16. PubMed ID: 591813
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sucrose gradient centrifugation sedimentation standards: a simplified technique.
    Grossman CJ; Uebel PL; Sholiton LJ; Nathan P
    Clin Chem; 1980 Jul; 26(8):1235. PubMed ID: 7190085
    [No Abstract]   [Full Text] [Related]  

  • 24. Estradiol and tamoxifen interaction at receptor sites at 37 C.
    Fishman JH
    Endocrinology; 1983 Sep; 113(3):1164-6. PubMed ID: 6191968
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Estrogen receptor separation employing sucrose deuterium oxide gradients generated during sample centrifugation.
    Scholl S; Lippman ME
    Breast Cancer Res Treat; 1985; 5(1):47-50. PubMed ID: 2983797
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multiple estrogen binding sites in the uterus: stereochemistry of receptor and non-receptor binding of diethylstilbestrol and its metabolites.
    Chae K; Johnston SH; Korach KS
    J Steroid Biochem Mol Biol; 1991 Jan; 38(1):35-42. PubMed ID: 1997122
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Site-specific antibodies to the DNA-binding domain of estrogen receptor distinguish this protein from the 3H-estradiol-binding protein in pancreas.
    Grossman A; Traish A
    Life Sci; 1992; 51(11):859-67. PubMed ID: 1381803
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of binding of [3H]Estradiol to the cytosol fraction of rat pancreas: comparison with sites in the cytosol of uterus.
    Boctor AM; Band P; Grossman A
    Endocrinology; 1983 Aug; 113(2):453-62. PubMed ID: 6872936
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rapid vertical tube rotor gradient assay for binding of 2,3,7,8-tetrachlorodibenzo-p-dioxin to the Ah receptor.
    Tsui HW; Okey AB
    Can J Physiol Pharmacol; 1981 Sep; 59(9):927-31. PubMed ID: 7296396
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Properties of the estrogen receptor in the human oviduct and its interaction with ethinylestradiol and mestranol in vitro.
    Muechler EK; Kohler D
    J Clin Endocrinol Metab; 1980 Nov; 51(5):962-7. PubMed ID: 7419693
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sedimentation profiles of the oestrogen receptor from breast tumours of man and rat using vertical-tube rotor centrifugation.
    Freedman B; Hawkins RA
    J Endocrinol; 1980 Sep; 86(3):431-42. PubMed ID: 7191881
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A comparison of 11 beta-chloromethylestradiol and tamoxifen aziridine as affinity labeling reagents for estrogen receptors.
    Ratajczak T; Atrache V; Antes P; Comber M; Hähnel R
    Steroids; 1988; 51(5-6):499-518. PubMed ID: 3242173
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Estrogen receptor in human myoma tissue.
    Puukka MJ; Kontula KK; Kauppila AJ; Janne OA; Vihko RK
    Mol Cell Endocrinol; 1976 Nov; 6(1):35-44. PubMed ID: 1001806
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Estrogenic stimulation of the antiestrogen specific binding site in rat uterus and liver.
    Winneker RC; Clark JH
    Endocrinology; 1983 Jun; 112(6):1910-5. PubMed ID: 6682755
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of the physicochemical properties of uterine nuclear estrogen receptors bound to estradiol or 4-hydroxytamoxifen.
    Attardi B; Happe HK
    Endocrinology; 1986 Aug; 119(2):904-15. PubMed ID: 3732150
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Extensive in situ activation of nuclear estrogen receptors after exposure of murine uteri to [3H]estradiol or [3H]4-hydroxytamoxifen.
    Pavlik EJ; Nelson K; van Nagell JR; Donaldson ES; Walden ML; Gallion H; Kenady DE
    Endocrinology; 1987 Apr; 120(4):1608-14. PubMed ID: 3830064
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interaction of [3H] estradiol - and [3H] monohydroxytamoxifen-estrogen receptor complexes with a monoclonal antibody.
    Tate AC; DeSombre ER; Greene GL; Jensen EV; Jordan VC
    Breast Cancer Res Treat; 1983; 3(3):267-77. PubMed ID: 6671136
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Binding of [3H] monohydroxytamoxifen in ovarian carcinoma.
    Holt JA; Jordan VC; Tate AC; Lorincz MA
    Br J Obstet Gynaecol; 1983 Aug; 90(8):751-8. PubMed ID: 6882707
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Specific high-affinity oestradiol binding in rat ventral prostate.
    Ginsburg M; Jung-Testas I; Baulieu EE
    J Endocrinol; 1980 Nov; 87(2):285-92. PubMed ID: 7430923
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differentiation of estradiol receptors in rat uterine cytosol by sensitivity to tamoxifen.
    Fishman JH; Fishman J
    Biochem Biophys Res Commun; 1979 Mar; 87(2):550-8. PubMed ID: 444239
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.